NATIONAL RESEARCH CORP (NRC) Stock Fundamental Analysis
USA - NASDAQ:NRC - US6373722023 - Common Stock
14.8 USD
-1.09 (-6.86%)
14.8 USD
0 (0%)
Taking everything into account, NRC scores 4 out of 10 in our fundamental rating. NRC was compared to 101 industry peers in the Health Care Providers & Services industry. NRC scores excellent on profitability, but there are concerns on its financial health. NRC has a expensive valuation and it also scores bad on growth.
1. Profitability
1.1 Basic Checks
NRC had positive earnings in the past year.
In the past year NRC had a positive cash flow from operations.
Each year in the past 5 years NRC has been profitable.
Each year in the past 5 years NRC had a positive operating cash flow.
1.2 Ratios
NRC has a better Return On Assets (12.68%) than 98.02% of its industry peers.
NRC has a Return On Equity of 84.06%. This is amongst the best in the industry. NRC outperforms 99.01% of its industry peers.
NRC has a better Return On Invested Capital (20.28%) than 94.06% of its industry peers.
The Average Return On Invested Capital over the past 3 years for NRC is significantly above the industry average of 9.19%.
The last Return On Invested Capital (20.28%) for NRC is well below the 3 year average (37.15%), which needs to be investigated, but indicates that NRC had better years and this may not be a problem.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 12.68% | ||
| ROE | 84.06% | ||
| ROIC | 20.28% |
ROA(3y)22.78%
ROA(5y)24%
ROE(3y)62.21%
ROE(5y)57.67%
ROIC(3y)37.15%
ROIC(5y)35.26%
1.3 Margins
With an excellent Profit Margin value of 12.78%, NRC belongs to the best of the industry, outperforming 99.01% of the companies in the same industry.
NRC's Profit Margin has declined in the last couple of years.
NRC's Operating Margin of 19.88% is amongst the best of the industry. NRC outperforms 96.04% of its industry peers.
In the last couple of years the Operating Margin of NRC has declined.
NRC has a Gross Margin of 60.31%. This is amongst the best in the industry. NRC outperforms 81.19% of its industry peers.
NRC's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 19.88% | ||
| PM (TTM) | 12.78% | ||
| GM | 60.31% |
OM growth 3Y-10.18%
OM growth 5Y-5.95%
PM growth 3Y-11.83%
PM growth 5Y-7.25%
GM growth 3Y-2.32%
GM growth 5Y-1.11%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so NRC is creating value.
The number of shares outstanding for NRC has been reduced compared to 1 year ago.
The number of shares outstanding for NRC has been reduced compared to 5 years ago.
The debt/assets ratio for NRC is higher compared to a year ago.
2.2 Solvency
An Altman-Z score of 3.22 indicates that NRC is not in any danger for bankruptcy at the moment.
The Altman-Z score of NRC (3.22) is better than 66.34% of its industry peers.
The Debt to FCF ratio of NRC is 8.73, which is on the high side as it means it would take NRC, 8.73 years of fcf income to pay off all of its debts.
NRC has a Debt to FCF ratio (8.73) which is comparable to the rest of the industry.
NRC has a Debt/Equity ratio of 3.61. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of NRC (3.61) is worse than 77.23% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 3.61 | ||
| Debt/FCF | 8.73 | ||
| Altman-Z | 3.22 |
ROIC/WACC2.37
WACC8.54%
2.3 Liquidity
A Current Ratio of 0.70 indicates that NRC may have some problems paying its short term obligations.
The Current ratio of NRC (0.70) is worse than 86.14% of its industry peers.
NRC has a Quick Ratio of 0.70. This is a bad value and indicates that NRC is not financially healthy enough and could expect problems in meeting its short term obligations.
NRC has a Quick ratio of 0.70. This is amonst the worse of the industry: NRC underperforms 80.20% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.7 | ||
| Quick Ratio | 0.7 |
3. Growth
3.1 Past
NRC shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -36.26%.
The Earnings Per Share has been decreasing by -3.70% on average over the past years.
The Revenue has decreased by -4.08% in the past year.
NRC shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.25% yearly.
EPS 1Y (TTM)-36.26%
EPS 3Y-10.59%
EPS 5Y-3.7%
EPS Q2Q%-101.82%
Revenue 1Y (TTM)-4.08%
Revenue growth 3Y-1.13%
Revenue growth 5Y2.25%
Sales Q2Q%-2.8%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 19.22 indicates a rather expensive valuation of NRC.
67.33% of the companies in the same industry are more expensive than NRC, based on the Price/Earnings ratio.
NRC is valuated rather cheaply when we compare the Price/Earnings ratio to 27.38, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.22 | ||
| Fwd PE | N/A |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of NRC indicates a somewhat cheap valuation: NRC is cheaper than 60.40% of the companies listed in the same industry.
The rest of the industry has a similar Price/Free Cash Flow ratio as NRC.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 36.81 | ||
| EV/EBITDA | 12.91 |
4.3 Compensation for Growth
NRC has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 3.02%, NRC has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 2.43, NRC pays a better dividend. On top of this NRC pays more dividend than 95.05% of the companies listed in the same industry.
NRC's Dividend Yield is a higher than the S&P500 average which is at 2.38.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.02% |
5.2 History
The dividend of NRC decreases each year by -17.40%.
NRC has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)-17.4%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
NRC pays out 62.38% of its income as dividend. This is not a sustainable payout ratio.
The Dividend Rate of NRC has been decling, while earnings will also be declining. This means the current dividend is most likely not sustainable.
DP62.38%
EPS Next 2YN/A
EPS Next 3YN/A
14.8
-1.09 (-6.86%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners50.59%
Inst Owner Change0.23%
Ins Owners9.49%
Ins Owner Change10.89%
Market Cap341.29M
Analysts45
Price TargetN/A
Short Float %3.05%
Short Ratio3.83
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.02% |
Yearly Dividend0.48
Dividend Growth(5Y)-17.4%
DP62.38%
Div Incr Years0
Div Non Decr Years0
Ex-Date
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.22 | ||
| Fwd PE | N/A | ||
| P/S | 2.43 | ||
| P/FCF | 36.81 | ||
| P/OCF | 16.02 | ||
| P/B | 16 | ||
| P/tB | N/A | ||
| EV/EBITDA | 12.91 |
EPS(TTM)0.77
EY5.2%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.4
FCFY2.72%
OCF(TTM)0.92
OCFY6.24%
SpS6.08
BVpS0.92
TBVpS-2.05
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 12.68% | ||
| ROE | 84.06% | ||
| ROCE | 26.45% | ||
| ROIC | 20.28% | ||
| ROICexc | 21.34% | ||
| ROICexgc | 67.64% | ||
| OM | 19.88% | ||
| PM (TTM) | 12.78% | ||
| GM | 60.31% | ||
| FCFM | 6.61% |
ROA(3y)22.78%
ROA(5y)24%
ROE(3y)62.21%
ROE(5y)57.67%
ROIC(3y)37.15%
ROIC(5y)35.26%
ROICexc(3y)44.09%
ROICexc(5y)48.46%
ROICexgc(3y)273.96%
ROICexgc(5y)N/A
ROCE(3y)48.46%
ROCE(5y)46%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y-21.97%
ROICexc growth 5Y-12.09%
OM growth 3Y-10.18%
OM growth 5Y-5.95%
PM growth 3Y-11.83%
PM growth 5Y-7.25%
GM growth 3Y-2.32%
GM growth 5Y-1.11%
F-Score5
Asset Turnover0.99
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 3.61 | ||
| Debt/FCF | 8.73 | ||
| Debt/EBITDA | 2.25 | ||
| Cap/Depr | 189.66% | ||
| Cap/Sales | 8.58% | ||
| Interest Coverage | 9.03 | ||
| Cash Conversion | 62.23% | ||
| Profit Quality | 51.72% | ||
| Current Ratio | 0.7 | ||
| Quick Ratio | 0.7 | ||
| Altman-Z | 3.22 |
F-Score5
WACC8.54%
ROIC/WACC2.37
Cap/Depr(3y)236.79%
Cap/Depr(5y)169.97%
Cap/Sales(3y)9.3%
Cap/Sales(5y)6.92%
Profit Quality(3y)77.54%
Profit Quality(5y)88.07%
High Growth Momentum
Growth
EPS 1Y (TTM)-36.26%
EPS 3Y-10.59%
EPS 5Y-3.7%
EPS Q2Q%-101.82%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-4.08%
Revenue growth 3Y-1.13%
Revenue growth 5Y2.25%
Sales Q2Q%-2.8%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-29.67%
EBIT growth 3Y-11.19%
EBIT growth 5Y-3.83%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-56.39%
FCF growth 3Y-22.27%
FCF growth 5Y-11.96%
OCF growth 1Y-38.68%
OCF growth 3Y-9.26%
OCF growth 5Y-3.29%